• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Dx Deals: Abbott Closes Exact Sciences Acquisition, Takes Control of Cologuard Franchise

Dx Deals: Abbott Closes Exact Sciences Acquisition, Takes Control of Cologuard Franchise

by Ron Shinkman | Apr 14, 2026 | Deals-lir, Essential, Lab Industry Advisor

Biotech giant purchased the company for $21 billion, one of the largest deals in clinical lab history

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies

Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies

by Ron Shinkman | Mar 26, 2026 | Clinical Diagnostics Insider, Emerging Tests-dtet

The flow cytometry assay costs a fraction of traditional invasive bone marrow testing

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
ClearNote Health Launches Early Detection Test for Pancreatic Cancer

ClearNote Health Launches Early Detection Test for Pancreatic Cancer

by Ron Shinkman | Mar 26, 2026 | Clinical Diagnostics Insider, Emerging Tests-dtet

The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Turning Physics into a Diagnostic Signal for Bladder Cancer

Turning Physics into a Diagnostic Signal for Bladder Cancer

by Bree Foster, PhD | Mar 13, 2026 | Clinical Diagnostics Insider, Emerging Tests-dtet

A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: NeuroQure Launches Test for Early Autism Diagnosis

Diagnostics Pipeline: NeuroQure Launches Test for Early Autism Diagnosis

by Ron Shinkman | Mar 11, 2026 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

The skin-based test can be used on children as young as two days old

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2026 G2Intelligence.com